相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lung Tissues in Patients With Systemic Sclerosis Have Gene Expression Patterns Unique to Pulmonary Fibrosis and Pulmonary Hypertension
Eileen Hsu et al.
ARTHRITIS AND RHEUMATISM (2011)
Increased cysteinyl-leukotrienes and 8-isoprostane in exhaled breath condensate from systemic sclerosis patients
Ellen Tufvesson et al.
RHEUMATOLOGY (2010)
N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis
Edoardo Rosato et al.
ACTA PHARMACOLOGICA SINICA (2009)
The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients
Edoardo Rosato et al.
CLINICAL RHEUMATOLOGY (2009)
N-ACETYLCYSTEINE INFUSION IMPROVES HEPATIC PERFUSION IN THE EARLY STAGES OF SYSTEMIC SCLEROSIS
E. Rosato et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial
Juergen Behr et al.
RESPIRATORY RESEARCH (2009)
Molecular targets in pulmonary fibrosis - The myofibroblast in focus
Chris J. Scotton et al.
CHEST (2007)
The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease
Cynthia M. Magro et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
High-dose acetylcysteine in idiopathic pulmonary fibrosis
M Demedts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynaud's phenomenon
F Salsano et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2005)
Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR
R Colavitti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)